Nutley, NJ - An injectable form of ibandronate (Boniva, Roche/GlaxoSmithKline) that can be given once every three months has been approved by the US Food and Drug Administration (FDA) for treatment of ...

WASHINGTON, June 7 (Reuters) - Patients who want an injectable form of Roche Holding AG's bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not ...

A new treatment for osteoporosis that can be given just once every three months has been approved by the US Food and Drug Administration. A new treatment for osteoporosis that can be given just once ...

While drug shortages often are tied to manufacturing interruptions, Roche's ($RHHBY) injectable form of its osteoporosis drug Boniva will be in limited supply for ...

Many companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught off-guard by a lack of it, leading to a ...

March 31, 2005 — The U.S. Food and Drug Administration (FDA) has approved a once-monthly formulation of ibandronate sodium for the treatment and prevention of postmenopausal osteoporosis; entecavir ...

SAN FRANCISCO (MarketWatch) -- Roche and GlaxoSmithKline Plc said late Friday the Food and Drug Administration has approved Boniva Injection, the first intravenous medication for the treatment of ...

Add articles to your saved list and come back to them any time. The US manufacturers of a drug to treat osteoporosis in women who have gone through menopause say the Food and Drug Administration has ...

-- Consumers Alerted to Discontinue Use of Alcohol Prep Pads Packaged with Boniva® Injection, Fuzeon®, Nutropin A.Q. Pen®, Pegasys®, TNKase® Medicines -- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- ...

Unlike Boniva tablets, which people take once a month, Boniva injections are given once every three months. The U.S. Food and Drug Administration announced the shortage of Boniva vials on its website ...